Scleral lenses demonstrated safety and efficacy for treating ocular surface disease and irregular cornea/refractive ...

Recent analysis from the American Hospital Association reports an increase in inpatient acuity of 3 percent from 2019 to 2024 ...

MeiraGTx is advancing its investigational gene therapy toward expedited approval in the UK after 11 children who were born ...

Acuity Brands, Inc. (NYSE:AYI – Get Free Report) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the firm, MarketBeat reports. Three investment ...

Regis has over 90% of its available beds in single rooms and is looking to mainly provide comfortable single ensuite rooms with modern facilities to accommodate a wealthier elderly population. In ...

Allspring Global Investments Holdings LLC trimmed its holdings in shares of Acuity Brands, Inc. (NYSE:AYI – Free Report) by 9.5% during the fourth quarter, according to its most recent Form 13F filing ...

A stiffly written press release from Veradigm announced Big Changes to its board of directors–and an agreement with a major shareholder, Kent Lake PR LLC. The cooperation agreement with Kent Lake adds ...

Shares of MeiraGTx Holdings shares reached a 52-week high after the company said 11 children treated to date in a drug study gained visual acuity after treatment. The stock was recently up 9.1%, to $7 ...

Veradigm said today it was extending the plan, set to expire on Feb. 26, 2025, through to Aug. 20. Also, to reflect drops in the price of company common stock, the plan updates the exercise price for ...

The 307th Forward Resuscitative and Surgical Detachment is a team of highly skilled medical personnel who took time off their ...

Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...